ArticleJournal of atherosclerosis and thrombosis2025

Multilevel Factors Predict Medication Adherence and Efficacy within 12 Months in Patients Receiving PCSK9 Monoclonal Antibodies: The Findings from a Real-World Analysis in China.

Xiaomeng Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.